Herein, we present the case of a patient with stage IV lung adenocarcinoma with an EGFR L858R mutation, who developed peritoneal metastasis involving the small intestine, leading to intestinal obstruction and death following osimertinib resistance. Here, EGFR is linked to lung adenocarcinoma.